study of the associations between tt virus single and mixed infections with leukemia

results the tt virus infection was significantly found in 40 of 95 (42.1%) and 12 of 100 (12%) patients with leukemia and controls, respectively. the hbs-ag and hcv-ab were detected in 27 of 95 (28.4%) and 18 of 69 (26.1%) patients with leukemia but were not found in the controls. active cmv infection was also found in 11 of 69 (16%) patients and none of the controls. significant co-infection of tt virus was found with hbv (15 of 40; 37.5%), hcv (14 of 40; 35%) and cmv (7 of 40; 17.5%) in patients with leukemia. background the pathogenic association of transfusion transmitted virus or torque teno virus (tt virus) single and mixed infections with leukemia was under evaluation in these years but confront with controversies. this hypothesis is based on the higher prevalence of tt virus infection in patients with leukemia compared with controls. objectives the aim of this study was to determine the frequency of tt virus, cytomegalovirus (cmv), hepatitis b virus (hbv), and hepatitis c virus (hcv) infections in patients with leukemia and healthy controls. patients and methods in this cross sectional study, 95 patients with leukemia and 100 healthy controls who were admitted to the namazi hospital affiliated to the shiraz university of medical sciences, shiraz, iran, were enrolled between years 2012 and 2013. blood samples treated with edta were collected from each patient with leukemia and controls. the existence of tt virus infection was analyzed using the semi-nested pcr method. the immunological prevalence of hbv and hcv infections were evaluated using hbs-ag and hcv-ab elisa based protocols, respectively. active cmv infection was also evaluated using an immunofluorescence method. also risk factors of leukemia and viral infections were statistically analyzed in patients with leukemia. conclusions confirmation of the significantly higher frequency of tt virus, hbv, hcv and cmv single infection and their co-infection in patients with leukemia compared with healthy controls, emphasizes the determinative role of tt virus pathogenesis in clinical outcomes observed in patients with leukemia, which requires extensive evaluation by further studies.